Physician profile
Kanika Mody
NPI 1891941449
$107,142.59
in general payments reported to CMS, 2019-2025
14 companies · $35K in 2025
The $35K reported for 2025 was more than what 90% of Advanced Heart Failure and Transplant Cardiology providers received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,876 · 2020: $216 · 2021: $6,081 · 2022: $8,089 · 2023: $20K · 2024: $36K · 2025: $35K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $33K · Consulting Fee: $27K · Travel and Lodging: $20K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $33,000.00 |
| Consulting Fee | $27,167.50 |
| Travel and Lodging | $20,160.49 |
| Food and Beverage | $10,552.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $55,678.54 | 2019-2025 | Impella |
| Impulse Dynamics (USA) INC. | $26,928.62 | 2021-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $15,437.76 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Cvrx, INC. | $7,183.14 | 2021-2025 | Barostim Neo System |
| Ancora Heart, INC. | $1,160.29 | 2019-2025 | Accucinch |
| Medtronic, INC. | $171.10 | 2024-2025 | Symplicity G3, Ffrangio |
| Pfizer INC. | $132.55 | 2024 | |
| Bridgebio Pharma, INC. | $122.28 | 2025 | Attruby |
| Boston Scientific Corporation | $71.04 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $69.87 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $69.61 | 2025 | |
| Edwards Lifesciences Corporation | $59.98 | 2020 | |
| Kestra Medical Technology Services, INC. | $42.67 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $15.14 | 2025 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kanika Mody listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.